Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RARE
RARE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RARE News
Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical Inc.
5d ago
Globenewswire
Ultragenyx Pharmaceutical Securities Lawsuit Notification
6d ago
Globenewswire
Ultragenyx Pharmaceutical Class Action Notice
6d ago
Globenewswire
Proto Labs and Oracle Options Trading Activity
6d ago
NASDAQ.COM
Faruqi & Faruqi Investigates Ultragenyx Securities Litigation
6d ago
Globenewswire
Goldman Sachs Downgrades Ultragenyx to Neutral
6d ago
seekingalpha
Ultragenyx Faces Class Action Lawsuit
Mar 23 2026
Globenewswire
Class Action Lawsuit Reminder Against Ultragenyx Pharmaceutical Inc.
Mar 23 2026
Globenewswire
Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical Inc.
Mar 22 2026
Globenewswire
Faruqi & Faruqi Investigates Ultragenyx Securities Claims
Mar 22 2026
PRnewswire
Ultragenyx Pharmaceutical Class Action Notice
Mar 21 2026
Globenewswire
CNBC Launches Advocacy Platform for Rare Diseases
Mar 20 2026
CNBC
Ultragenyx Pharmaceutical Class Action Notice
Mar 20 2026
PRnewswire
Ultragenyx Pharmaceutical Faces Class Action Lawsuit for Securities Violations
Mar 19 2026
Globenewswire
Ultragenyx Faces Class Action Lawsuit Over Misleading Statements
Mar 19 2026
PRnewswire
Ultragenyx Securities Class Action Reminder
Mar 19 2026
Globenewswire
Show More News
